camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostatas audzēji - endokrīnā terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
mastijet forte suspensija ievadīšanai tesmenī
intervet international b.v., nīderlande - bacitracīns,neomicīnu,prednizolons,tetraciklīnu hydrochloridum - suspensija ievadīšanai tesmenī - laktējošas govis
nobilis rt+ibmulti+nd+eds emulsija injekcijām
intervet ireland ltd, Īrija - inactivated infectious bronchitis virus, serotype massachusetts, strain m41, inactivated newcastle disease virus, strain clone 30, inactivated avian rhinotracheitis virus, strain but 1#8544, inactivated infectious bronchitis virus, strain 249g, inactivated egg drop syndrome virus ’76, strain bc14 - emulsija injekcijām - vistas
weider® delicious gold whey (paziņots 2012.) pulveris
weider germany gmbh - pulveris
colief® zīdaiņu pilieni (2017.) šķidrums
crosscare ltd. - šķidrums
equilis strepe
intervet international bv - dzīvs dzēšanas mutants streptococcus equi celms tw928 - imūnsistēmas zirgu dzimtas dzīvniekiem - zirgi - zirgu imunizācijai pret streptococcus equi, lai samazinātu limfmezglu abscesu klīniskās pazīmes un parādīšanos. imūnsistēmas sākums: imunitātes sākums tiek noteikts divas nedēļas pēc primārās vakcinācijas. imunitātes ilgums: imunitātes ilgums ir līdz trim mēnešiem. vakcīna ir paredzēta izmantošanai zirgiem, kuriem ir skaidri identificēts streptococcus equi infekcijas risks sakarā ar saskari ar zirgiem no vietām, kur ir zināms, ka šis patogēns ir zināms. e. staļļi ar zirgiem, kuri dodas uz šajās zonās notiekošiem šoviem vai sacensībām, vai staļļi, no kuriem iegūst zirgus vai iegūst no tām šādas vietas.
onglyza
astrazeneca ab - saksagliptīns - cukura diabēts, 2. tips - cukura diabēts - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
amicor 10 mg apvalkotās tabletes
medochemie ltd., cyprus - atorvastatīns - apvalkotā tablete - 10 mg
amicor 20 mg apvalkotās tabletes
medochemie ltd., cyprus - atorvastatīns - apvalkotā tablete - 20 mg
set-vac emulsija injekcijām
optim vet, latvija - inactivated salmonella typhimurium, strain dt104, inactivated salmonella enteritidis pt4 - emulsija injekcijām - vistas